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ABSTRACT
The adenomatous polyposis coli (Apc) protein regulates diverse
effector pathways essential for tissue homeostasis. Truncating
oncogenic mutations in Apc removing its Wnt pathway and
microtubule regulatory domains drives intestinal epithelia
tumorigenesis. Exuberant cell proliferation is one well-established
consequence of oncogenic Wnt pathway activity; however, the
contribution of other deregulated molecular circuits to tumorigenesis
has not been fully examined. Using in vivo and organoid models of
intestinal epithelial tumorigenesis we found that Wnt pathway activity
controls intestinal epithelial villi and crypt structure, morphological
features lost upon Apc inactivation. Although the Wnt pathway target
gene c-Myc (also known as Myc) has critical roles in regulating cell
proliferation and tumorigenesis, Apc specification of intestinal epithelial
morphology is independent of the Wnt-responsive Myc-335 (also
known as Rr21) regulatory element. We further demonstrate that Apc
inactivation disrupts the microtubule cytoskeleton and consequently
localisation of organelles without affecting the distribution of the actin
cytoskeleton and associated components. Our data indicates the direct
control over microtubule dynamics by Apc through an independent
molecular circuit. Our study stratifies three independent Apc
effector pathways in the intestinal epithelial controlling: (1)
proliferation, (2) microtubule dynamics and (3) epithelial morphology.
This article has an associated First Person interview with the first
author of the paper.
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INTRODUCTION
The intestinal tract (small intestine and colon) hosts a highly dynamic
enterocyte monolayer that undergoes complete self-renewal every 3
to 5 days. The basic units of the intestinal epithelium are adjacent
invaginations, termed crypts of Lieberkühn (Fig. 1A,B), each of
which serves as a semi-autonomous cell production factory with a
remarkably high proliferation rate – along the murine intestinal tract,
crypts are composed of an average of 700 cells that produce up to 20
cells per hour in the small intestine or 7 cells per hour in the colon (de
Rodriguez et al., 1978; Potten et al., 1982; Sunter et al., 1979).
Throughout the enterocyte monolayer, each cell is spatially restricted,
selective for homotypic and heterotypic cell-specific interactions, and
is highly polarised with defined apical, lateral and basal faces,
characteristics that are critical to epithelial barrier and transport
functions. The hierarchal organisation of the enterocyte monolayer,
from the stem cells at the base of crypts to differentiated cells types
facing the gut lumen, is achieved through the highly regimented
balance of rapid cellular proliferation, cellular organisation and
morphology of the epithelial monolayer (Gehart and Clevers, 2019).
Malignant transformation as a result of mutational inactivation of
the tumour suppressor gene adenomatous polyposis coli (APC)
compromises tissue organisation of the intestinal epithelium (Dow
et al., 2015; Kinzler and Vogelstein, 1996; Fearon and Volgestein,
1990). Somatic mutations in APC are widely regarded as the earliest
genetic lesion in 80-90% of sporadic colon cancers (Groden et al.,
1991). Perhaps surprisingly, mutational inactivation of APC reveals an
oncogenic vulnerability largely restricted to the intestinal epithelium.
Thus, individuals with familial adenomatous polyposis (FAP) that are
heterozygous for a germline mutation inactivating one allele of APC
(Su et al., 1992) exhibit spontaneous loss of heterozygosity that leads
to hundreds of tumours, mostly restricted to the intestinal epithelium.
The well-established murine model of FAP, ApcMin/+ (multiple
intestinal neoplasia; Min), follows a similar pattern of tumour
development – despite mono-allelic inactivation of Apc in every cell
in the body, tumorigenesis is almost exclusive to the intestinal
epithelium (Moser et al., 1990, 1995; Ren et al., 2019; Su et al., 1992).
Apc is a large multidomain protein that governs a plethora of
effector pathways regulating cellular and tissue homeostasis
(Nelson and Näthke, 2013). The molecular roles of Apc are
generally ascribed to the regulation of Wnt pathway activity, a key
determinant of stem cell multipotency and proliferation within the
crypt. Pathway activity is sustained within the stem cell niche by
redundant sources of Wnt ligands derived from adjacent Paneth
cells and the underlying mesenchyme (Aoki et al., 2016; Farin et al.,
2012; Gregorieff et al., 2005; Stzepourginski et al., 2017; Valenta
et al., 2016; Zou et al., 2018), and potentiated by cellular
engagement of LGR family receptors by R-spondins derived from
specific mesenchymal cells (Yan et al., 2017).
Oncogenic APC inactivation in colorectal cancer follows a
unique pattern of somatic changes – at least one APC allele harbours
mutations that are largely confined to a short segment within exon
15 of the gene referred to as the mutation cluster region (MCR;
Fig. 1C), resulting in the expression of truncated APC. The other
allele is most often silenced or incurs the same or a more severe
truncating mutations (Crabtree et al., 2003; Lamlum et al., 1999;
Rowan et al., 2000). Tumours arising from truncating mutations in
exon 14 of the mouse Apc gene found in the Min mouse line
(Fig. 1C), equivalent to human exon 15, display many features
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The truncated Apc protein lacks regulatory protein-protein
interaction domains for the Wnt pathway regulators β-catenin
(also known as Ctnnb1) and Axin1 (Fig. 1C), explaining oncogenic
Wnt pathway activation upon loss of heterozygosity in murine
models. Extensive investigation of oncogenic Wnt pathway activity
in cells lacking Apc points to a key role in the regulation of intestinal
epithelial cell proliferation through the Wnt pathway target gene
c-Myc (Dave et al., 2017; He et al., 1998; Oskarsson and Trumpp,
2005; Sansom et al., 2007; Sur et al., 2012).
Truncated Apc protein also lacks the C-terminal microtubule end
binding protein 1 (EB1, also known as Mapre1) binding domain and
a basic domain thought to bind directly to microtubules (Fig. 1C;
Deka et al., 1998). However, the molecular consequence of
C-terminal Apc truncations and removal of the microtubule and
EB1 binding domains is controversial. Apc-mediated stabilisation of
microtubules via its C-terminal domains supports the establishment
of parallel arrays of microtubules in a polarised cell (Mogensen et al.,
2002; Zumbrunn et al., 2001), and Apc is known to regulate
cytoskeletal rearrangements that accompany cell motility, cell
division and tissue organisation through control of microtubule
dynamics (Moseley et al., 2007; Munemitsu et al., 1994; Näthke
et al., 1996; Smith et al., 1994). Consistent with these observations is
that Apc localizes to the plus-end tips of microtubules, centrosomes
and microtubule spindles, and at the interface of microtubules and
Fig. 1. Compromised morphology of the
monolayer and cellular organisation in Apc-
deficient intestinal epithelia. (A) Haematoxylin
and eosin stain of normal ApcMin/+ murine
intestinal epithelia and adjacentApcMin/− tumour.
The outsets show zoomed images of crypts from
normal ApcMin/+ murine intestinal epithelia and
gland-like structures from ApcMin/− tumours.
(B) Fluorescent confocal microscope imaging of
sections of ApcMin/+ small intestinal epithelia (top
panels) and ApcMin/− tumours (bottom panels).
The left panels show sections that are labelled
with a fluorescent antibody against Ki67 (green).
Intracellular vesicles are labelled with fluorescent
fUEA (red). The middle panels show sections
that are labelled with an antibody against
lysozyme to mark Paneth cell vesicles. The right
panels show sections that are labelled with an
antibody against β-catenin. Nuclei in all sections
are labelled with DAPI (blue). In the insets, ‘A’
marks the apical domain of cells and ‘B’ marks
the basal domain. The curved dashed line
delineates themonolayer of the base of the crypt.
(C) Linear schematic of the Apc protein showing
constituent protein-protein interaction domains.
Arm, armadillo repeat domain; EB1, EB1-binding
domain; MT/basic, the microtubule binding
domain containing basic amino acids; Oligo,
oligomerisation domain; SAMP1-3, Axin1-
binding SAMP domains 1-3;. Ovals refer to
15- and 20-amino acid β-catenin binding
domains (grey and dark grey, respectively). MCR
marks the corresponding mutational cluster
region in human APC. The table shows the
mouse models of Apc deficiency used in this
study, and domain structure of the expressed
truncated forms of Apc alongside the genotype of
the various models discussed in the main text.
Additionally, the propensity for intestinal
epithelial tumorigenesis in the mouse models,
and the ability of the expressed truncated form of
Apc to regulate Wnt pathway activity, is shown.
Scale bars: 200 μm (A); 50 μm (B).
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kinetichores during mitosis (reviewed by Näthke, 2004a). It is not
clear whether the truncating mutations in Apc decrease its binding to
microtubules or its capacity to stabilize the microtubule plus ends
(Kroboth et al., 2007; Munemitsu et al., 1994; Smith et al., 1994;
Zumbrunn et al., 2001). Furthermore, loss of Apc C-terminal
microtubule and EB1 interaction domains in mouse embryonic
fibroblasts and differentiated embryonic stem cells does not affect the
distribution of β-tubulin (also known as Tubb1), EB1 andApc (Lewis
et al., 2012; Smits et al., 1999).
In vivo mouse models have investigated whether loss of the
C-terminal microtubule and EB1 binding domains of Apc are
sufficient to drive intestinal epithelial tumorigenesis. Apc1638T/1638T
mice express a version of Apc lacking the C-terminal domains but
retaining the ability to regulate Wnt pathway activity, and do not
present with intestinal epithelial tumours (Smits et al., 1999;
Fig. 1C). Conversely,ApcΔSAMP/+ mice, expressing a version of Apc
unable to regulate Wnt pathway activity but retaining the
microtubule and EB1 binding domains, develop tumours with the
same frequency and kinetics as the corresponding Apc1322/+ mice
that express Apc lacking these domains (Lewis et al., 2012;
Fig. 1C). Thus, the ability of Apc to interact with microtubules and
EB1 does not, on its own, drive intestinal epithelial tumorigenesis.
Nonetheless, the potential contribution of the loss of the Apc
microtubule and EB1 binding domains to intestinal tumorigenesis
has not been determined.
Herein, we stratify molecular pathways regulated by Apc in the
murine intestinal epithelia by defining the molecular and phenotypic
consequences in the small intestinal epithelia and corresponding
organoids caused byApc inactivation. In addition to the deregulation of
cell proliferation, we find that Apc inactivation disrupts themorphology
of the intestinal epithelial monolayer and compromises the
functional integrity of the microtubule cytoskeleton in component
enterocytes. These emergent malignant properties are the direct
consequence of Apc inactivation and are controlled by different and
independent molecular systems. Therefore, (1) enterocyte proliferation,
(2) microtubule dynamics and (3) epithelial morphology are regulated
by three separate effector pathways that, under the control of Apc,
buttress normal intestinal epithelial homeostasis against malignant
transformation.
RESULTS
Compromised intracellular organisation and tissue
morphology in ApcMin/− tumours
Over the course of 110 days, ApcMin/+ mice develop 30-40 adenomas
in the small intestine, the result of loss of heterozygosity of the wild-
type Apc allele (Moser et al., 1995; Su et al., 1992). Such ApcMin/−
tumours are composed of gland-like structures that maintain an
epithelial monolayer yet lack the morphological hallmarks of crypt
and villus compartments, and the hierarchal cellular organisation of
the wild-type epithelia (Fig. 1A). For instance, Ki67+ proliferative
stem cells and the transit amplifying cellular compartment, normally
disposed basally within crypts, are instead interspersed throughout
the monolayer of the tumour gland-like structures (Fig. 1B). We used
fluorescently-labelledUlex europaeus agglutinin (fUEA) to visualise
secretory vesicles that, in wild-type tissue, are found apically within
the mechanically rigid keystone-shaped Paneth cells in the crypts or
columnar-shaped goblet cells in the villi (Langlands et al., 2016;
Fig. 1B). However, UEA+ cells in ApcMin/− tumours were
interspersed throughout the glandular monolayer, were of variable
shapes and failed to maintain their characteristic clustered apical
localisation (Fig. 1B). We observed the identical phenotype using an
antibody raised against lysozyme – Paneth cells no longer maintained
their shape, size and clustered localisation to the crypt base, and
intracellular secretory vesicles were no longer apically restricted
(Fig. 1B). In contrast, β-catenin maintained its characteristic
localisation pattern at the cell periphery juxtaposed to cell-cell
contacts in ApcMin/− tumour cells (Fig. 1B). In the larger proportion
of ApcMin/− tumour cells, we observed high expression levels of
β-catenin and localisation to the nucleus, an established consequence
of Apc deficiency (Polakis, 2012). In general, tumour cells failed to
maintain the consistent columnar cell shape and size of wild-type
epithelial cells, yet they aligned as a monolayer to form the gland-like
structures (Fig. 1A,B). We also note that, as opposed to wild-type
enterocytes, ApcMin/− tumour cells contained nuclei of variable
shapes and sizes that failed to align along the plane of the monolayer.
We conclude that, in addition to driving deregulated epithelial cell
proliferation and the disruption of tissue morphology, Apc
inactivation compromises some aspects of intracellular organisation.
Defective regulation of microtubule function in
ApcMin/− tumours
The cytoskeleton provides the physical framework for intracellular
organisation and cell polarity defined by localised dynamic
polymerisation/depolymerisation of actin and tubulin monomers
(Li and Gundersen, 2008; Rodriguez-Boulan and Macara, 2014).
Apc harbours an array of protein-protein interaction domains with
established roles in regulating F-actin and microtubule dynamics
within intestinal epithelial cells (Fig. 1C) (Kawasaki et al., 2000;
Munemitsu et al., 1994; Näthke, 2004b; Rosin-Arbesfeld et al.,
2001; Tirnauer, 2004; Zumbrunn et al., 2001). We examined the
localisation of the cytoskeleton in intestinal epithelial and ApcMin/−
tumour cells using a series of fluorescent probes for F-actin,
microtubules and known protein interactors. Consistent with a
previous study (Fatehullah et al., 2013), all ApcMin/− tumour cells
maintained the correct disposition and configuration of actin
cytoskeletal components – F-actin was concentrated along the
apical face of the epithelial cells (Pelaseyed and Bretscher, 2018),
β4-integrin (also known as Itgb4), which anchors enterocytes to the
underlying lamina propria, was found at the cell base (Fatehullah
et al., 2013), β-catenin localised adjacent to cell-cell contacts and
the tight junction organiser ZO-1 (also known as Tjp1) was
positioned apically at cellular junctions (Lee et al., 2018; Fig. 1B,
Fig. 2A, Table 1).
In contrast, components of the microtubule cytoskeleton in
ApcMin/− tumour cells were disorganised; microtubules, normally
orientated along the apical-basal axis were instead disjointed and
diffuse, often appearing as punctate (Fig. 2B). We used an antibody
raised against the acetylated form of α-tubulin and found that the
signal was concentrated at the apical domain of cells, in line with
previously published data (Quinones et al., 2011). However, in
tumour cells, acetylated α-tubulin was instead delocalised and
diffuse (Fig. S1A). As a quantitative measure of the functional
microtubule cytoskeleton, we determined the localisation of
intracellular organelles whose location and positioning are
dependent on microtubules. Predictably, we found that the
normally strict basal positioning of nuclei, apical positioning of
intracellular vesicles and the supranuclear localisation of the Golgi
resident protein ZFPL1 and the centrosome marker pericentrin in
wild-type intestinal epithelia was lost in ApcMin/− tumour cells.
Instead we observed signals for the Golgi and centrosome split into
multiple puncta and mislocalised (Fig. 2C, Table 1). To preclude
mislocalisation of the Golgi as the consequence of cells undergoing
cell division (Thyberg and Moskalewski, 1999), we co-stained
intestinal epithelial sections with an antibody against the mitotic
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marker phospho-histone 3 (PH3) – tumour cells displayed
delocalised Golgi in the absence of detectable levels of PH3
(Fig. S1B). We quantified localisation data for components
associated with the microtubule and actin cytoskeleton (presented
in Table 1). Our results indicate that normal localisation of the actin
cytoskeleton is maintained in ApcMin/− intestinal epithelial tumour
cells, whereas the localisation and functional integrity of the
microtubule cytoskeleton is compromised.
We reasoned that the C-terminal microtubule and EB1 binding
domains of Apc may be critical for the regulation of the microtubule
cytoskeleton. The Apc1638T/1638T mouse strain is homozygous for a
truncating mutation in Apc that deletes the C-terminal microtubule
and EB1 binding domains (Fig. 1C). However, as opposed to Apc
expressed in ApcMin/+ mice, the Apc1638T protein retains the Axin1
interaction domain and therefore retains regulatory control overWnt
pathway activity; Apc1638T/1638T mice do not develop intestinal
epithelial tumours (Smits et al., 1999; Fig. 1C). As the small
intestine epithelia ofApc1638T/1638Tmice exhibit normal localisation
of intact Golgi and fUEA+ Paneth cell vesicles (Fig. S1C), we
conclude that loss of the C-terminal microtubule and EB1 binding
domains of Apc alone do not compromise regulation of the
microtubule cytoskeleton or intestinal epithelial morphology.
Organoids accurately recapitulate the molecular and
phenotypic consequences of APC inactivation in the
intestinal epithelium
We generated organoid lines from wild type, ApcMin/+ intestinal
epithelia and ApcMin/− tumour cells as an experimentally tractable
Fig. 2. Apc inactivation does not affect the localisation of the actin
cytoskeleton yet compromises microtubule dynamics. (A) Fluorescence
confocal microscopy of small intestinal epithelial sections fromApcMin/+ mouse
(top panels) and ApcMin/− tumours (bottom panels). Sections were labelled
with fluorescent phalloidin (green; left panel), an antibody against β4-integrin
(green; middle panel) and an antibody against ZO-1 (red; right panel).
(B) Confocal images of sections from ApcMin/+ mouse (top panels) and
ApcMin/− tumours (bottom panels) labelled with an antibody against β-tubulin.
The top right panels are zoomed images of crypt and villi regions and the
bottom right panel is a zoomed image of a region of the tumour. Arrowheads
indicate the position of individual microtubules aligning along the apical-basal
axis of epithelial cells. (C) Sections of small intestinal epithelia from ApcMin/+
mouse (top panels) and ApcMin/− tumours (bottom panels). The left panels
show sections labelled with fluorescent UEA (red) and an antibody against ZO-1
(green). The middle panels show sections labelled with an antibody against
pericentrin (red) to visualise the centrosome. The right panels show sections
labelled with an antibody against the Golgi resident protein ZFPL1 (green). All
sections were co-labelled with DAPI (blue). In all panels, ‘A’ marks the apical
domain of cells and ‘B’, the basal domain. Scale bars: 50 μm (A,C); 100 μm (B).
Table 1. Phenotypic analysis of ApcMin/+ epithelial cells and ApcMin/−
tumour cells








fUEA+ vesicles 99±8 40±11**
Nuclei 95±10 60±8*
Values represent the percentage of cells that display the correct localisation
and disposition for each organelle and cellular structure analysed. Nuclei are
considered localised if they follow the plane of the monolayer; for UEA+
vesicles, Golgi and centrosome, correct localisation is evaluated as
supranuclear and clustered. Data are mean±s.d. Levels of significance from
ApcMin/+ epithelial cells were evaluated by an unpaired one-tailed Student’s
t-test. (*P<0.01, **P<0.001; n=3 biological replicates).
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model system for determining the molecular mechanisms linking
Apc to microtubule integrity and epithelial morphology. Organoids
derived from normal tissue form an epithelial monolayer, replete
with crypts, that maintains the three-dimensional cellular
organisation and hierarchy found in vivo. In contrast, tumouroids,
organoids derived from ApcMin/− tumour cells, form cystic
structures lacking morphological features of the intestinal
epithelial monolayer, such as crypts (Sato et al., 2011).
Using a series of fluorescent probes, we found that F-actin and
associated molecular components β4-integrin, β-catenin and ZO-1
maintained their intracellular localisation in both organoid and
tumouroid cells (Fig. 3A). Note that in some cases, the middle
portion of the spherical tumouroid collapses and is captured in some
confocal sections. Consistent with our observations in intestinal
epithelial tissue from ApcMin/− tumours, the organisation and
function of the microtubule cytoskeleton was compromised:
β-tubulin was no longer polarised in microtubules along the
apical-basal axis of cells but was instead dispersed throughout
tumouroid cells and acetylated α-tubulin was delocalised (Fig. 3B).
We also found that nuclei varied in shape and size and did not follow
the plane of the tumouroid monolayer and centrosomes, and Golgi
were split into multiple puncta distributed throughout the cell body
(Fig. 3C). Quantification of the centrosome and Golgi localisation
in tumouroids indicated that they were mispositioned in over 35%
and 50% of cases, respectively (Fig. 3D). Consistent with our in vivo
results, our organoid data confirm that Apc inactivation in the
intestinal epithelial monolayer leads to deregulation of microtubule
dynamics and loss of intracellular organisation with the absence of
detectable effects on the actin cytoskeleton.
Apc deficiency directly compromises intracellular
organisation and tissue morphology
It is possible that intestinal epithelial tumours from 110-day-old
ApcMin/+ mice, and organoids derived from them, have acquired
additional somatic changes that contribute to phenotype. To
determine the immediate and direct effects of Apc inactivation,
we created a switchable organoid model of tumorigenesis that relies
on the inducible expression of a previously validated shRNA
targeting Apc (Dow et al., 2015) (Fig. S2A). Induction of shApc in
organoids depleted Apc mRNA concurrent with the expression of
mCherry, and leads to the intraconversion of organoids into a cystic
tumouroid structure (Fig. S2B-D). Importantly, we observed a
reversible increase in expression of the Wnt pathway target gene
c-Myc (Fig. S2E).
Consistent with the appearance of ApcMin/− tumours and
tumouroids, Apc depletion in organoids resulted in the
mislocalisation of UEA+ intracellular vesicles, as well as Golgi and
centrosome fragmentation and mislocalisation (Fig. 4A). Importantly,
all hallmarks of intracellular disorganisation and compromised tissue
morphology were reversed upon Apc re-expression, leading to the
appearance of ‘normal’ organoids (Fig. 4A). Our switchable in vitro
tumorigenesis model confirms that compromised epithelial
morphology and intracellular disorganisation are the direct
consequence of Apc inactivation.
Apc regulation of intestinal epithelial morphology and
microtubule dynamics are discrete
Ubiquitous activation of Wnt pathway activity in organoid cells by
treatment with Wnt3A-conditioned medium leads to the
intraconversion of organoids into cystic tumouroid-like structures
(Farin et al., 2012) that we refer to asWnt-oids (Fig. 4B). Although the
morphology of theWnt-oid epithelial monolayer is compromised, they
are distinct from tumouroids in that the Golgi and centrosome retain
their normal apical position in component cells (Fig. 4B) – greater than
80% of Wnt-oid cells show apical localisation of the Golgi and
centrosome as opposed to less than 65% in tumouroid cells (Fig. 4B).
We conclude that Apc regulation of intestinal epithelial morphology
through Wnt pathway regulation is not coupled to its function in
regulating microtubule dynamics and intracellular organisation.
We carried out the complementary experiment, selectively
deregulating microtubule dynamics in organoids and determining
the consequence on epithelial morphology. We treated organoids with
a low concentration (100 nM) of the microtubule depolymerising
agent nocodazole (Vasquez et al., 1997) for 48 h, a time point
sufficient for the conversion of organoids to Wnt-oids with Wnt3A
treatment. Treated organoid and Wnt-oid cells displayed the
characteristic mislocalisation of fragmented Golgi that was reversed
after 24 h post-nocodazole withdrawal (Fig. 4C,D). Importantly,
throughout the experiments, nocodazole-treated organoids maintained
intestinal epithelial crypt structures (Fig. 4C,D), indicating that
maintenance of intestinal organisation and microtubule dynamics are
not dependent on one another. Combined with our Apc loss-of-
function studies, these data suggest that Apc-dependent control of
intracellular organisation and epithelial morphology rely on
independent molecular circuits.
Loss of a Wnt-responsive enhancer element upstream of
c-Myc does not impact intestinal epithelial morphology
Previous studies have indicated that Apc inactivation in the
intestinal epithelia compromising Wnt pathway-dependent
regulation of c-Myc expression is the critical mediator of
malignant transformation in vivo (Dave et al., 2017; Sansom
et al., 2006; Sur et al., 2012). Although the removal of the Wnt
pathway-responsive enhancer element upstream of c-Myc, which
carries binding sites for the Wnt pathway effector transcription
factor Tcf7l2 (Myc-335−/− mice; Fig. S3) (Sur et al., 2012), only
modestly reduces c-Myc expression, it attenuates small intestinal
epithelial tumorigenesis, when combined with the ApcMin/+ allele,
by ∼70% multiplicity (Sur et al., 2012). We derived organoids from
Myc-335−/− mice to test whether deregulated epithelial
morphology, one phenotypic consequence of Wnt pathway
activity imposed by Apc inactivation, was altered after deletion of
the Wnt-responsive enhancer element upstream of c-Myc.
Wnt3A-conditioned medium treatment of Myc-335−/− and wild-
type organoids indicated identical kinetics and frequency of Wnt-
oid formation (Fig. 5A,B) that retained the normal Golgi apical
localisation (Fig. 5C). Furthermore, over the 7-day time course of
Wnt3A treatment, we observed no differences in cell proliferation
within wild-type and Myc-335−/− organoids measured by Wnt-oid
diameter (Fig. 5D). Taken together, our data suggest that regulation
of intracellular organisation and epithelial tissue morphology by
Wnt pathway activity is independent of regulation of c-Myc
expression via Myc-335.
DISCUSSION
In this study, we unmasked individual molecular systems controlled
by Apc in the intestinal epithelia through loss of function. Oncogenic
Apc mutations are the principal driver of colon epithelial
tumorigenesis and are sufficient for malignant transformation of the
colon and small intestinal epithelia. We stratify three emergent
phenotypes in the murine intestinal epithelia that are the direct
consequence of oncogenic Apc mutations: deregulated proliferation,
disrupted epithelial morphology and compromised microtubule
dynamics leading to defective intracellular organisation.
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Fig. 3. See next page for legend.
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In the intestinal epithelia, Apc activity restricts enterocyte
proliferation through stringent control of the Wnt pathway-
dependent transcriptional programme. In particular, regulated
expression of the Wnt pathway target gene c-Myc constrains
proliferation to discrete localised niches, providing a key molecular
barrier to malignant transformation (Dave et al., 2017; Quyn et al.,
2010; Sur et al., 2012); although oncogenic Apc mutations in the
intestinal epithelia are sufficient to drive neoplastic growth, the
absence of c-Myc expression attenuates all transforming properties
of Apc inactivation in vivo (Sansom et al., 2006). Less well
understood is how oncogenic Apc mutations deregulate epithelial
morphology and intracellular organisation. We have established that
organoids and their Apc-deficient counterparts, tumouroids, are a
tractable model that effectively recapitulates the morphological and
organisational hallmarks modelling the transition between intestinal
epithelia and tumours.
Treatment of organoids with Wnt3A drives their intraconversion
into cystic tumouroid-like structures, termed Wnt-oids, that, in
contrast to tumouroids, maintain intracellular organisation of the
component cells. Our interpretation is that Wnt3A treatment leads
to selective inhibition of Wnt pathway regulation by Apc,
compromising constraints on epithelial morphology but retaining
the integrity of the microtubule cytoskeleton and intracellular
organisation, supporting the notion that regulation of epithelial
morphology and cytoskeletal integrity are uncoupled. Conversely,
selective destabilisation of microtubules compromises intracellular
organisation in component organoid cells, yet normal morphology
of the epithelia monolayer is retained. Taken together, our data
support a model whereby Apc controls enterocyte proliferation and
epithelial morphology through Wnt pathway regulation, and
regulates the microtubule cytoskeleton and intracellular
organisation through other separate pathways (Fig. 5E).
How then does Apc regulation of Wnt pathway activity impact
the morphology of the epithelial monolayer? Our data support direct
control of epithelial morphology by Wnt pathway activity rather
than an inability of organisational constraints to copewith exuberant
proliferation. In the intestinal epithelia, neoplastic growth is the
result of precocious Wnt pathway target gene expression driving
deregulated expression of the Wnt pathway target gene c-Myc.
Deregulated c-Myc expression is regarded as the major culprit in all
transforming phenotypes attributed to Apc loss in vivo (Sansom
et al., 2007). However, using the Myc-335−/− organoids, we find
that although the modest deregulation of c-Myc expression observed
in vivo (Sur et al., 2012) is sufficient to reduce transforming
properties of Apc inactivation, it does not alter Wnt pathway
regulation of intestinal epithelial morphology or cellular
organisation in our organoid system. Moreover, within the time
frame of our experiments, we did not observe any changes in the rate
of proliferation accompanying the intraconversion of organoids to
Wnt-oids. Together, our data suggest that Apc control of epithelial
morphology is not wholly dependent on Myc-335-mediated Wnt
pathway regulation of c-Myc expression, nor is it the result of
increased proliferative pressure on organisational constraints on the
epithelial monolayer.
It will be important to identify Wnt pathway targets that control
intestinal epithelial morphology – we anticipate that targeted
modulation of such genes may provide therapeutic value for
preventing or even reversing the compromised epithelial morphology
accompanying malignant transformation of the intestinal epithelia. The
intraconversion between organoids andWnt-oids is a ready-made assay
system for rapidly testing sufficiency of Wnt pathway candidate target
genes by their targeted loss of function; a list of such candidates has
been previously identified by Sansom et al. (2007).
One striking observation was that Apc regulates the integrity of
the microtubule cytoskeleton and consequently the intracellular
location of organelles, such as the nucleus, Golgi, centrosome and
intracellular vesicles. Although control of the microtubule
cytoskeleton may be mediated directly by the Apc C-terminal
microtubule and/or EB1 binding domains (Morrison et al., 1998;
Munemitsu et al., 1994), it is also possible that Wnt pathway
regulatory components downstream of Apc, or even Wnt pathway
transcriptional targets, contribute to microtubule integrity. For
example, truncated Apc in Apc1638T/1638T mice retains the ability to
regulate Wnt pathway activity and maintain the integrity of the
microtubule cytoskeleton (Smits et al., 1999). Our interpretation is
that regulation of the Wnt pathway suppresses defects in the
microtubule cytoskeleton in vivo. It remains to be determined
whether this is the case in the intestinal epithelial-autonomous
milieu of in vitro organoid culture.
In colon cancer, oncogenicmutations that inactivate Apc are tenfold
more prevalent than oncogenic mutations in other Wnt pathway
regulatory components, suggesting that functions other than Wnt
pathway deregulation contribute to disease aetiology. Although
compromised microtubule integrity is a likely consequence of Apc
truncations that delete C-terminal microtubule and EB1 binding
domains, it is unlikely to impact tumorigenesis – the presence of
C-terminal microtubule and EB1 binding domains in truncated
versions of Apc has no impact on tumorigenesis (Lewis et al., 2012).
However, one intriguing possibility is that compromised microtubule
integrity in Apc mutant tumour cells contributes to chromosome
instability (CIN). CIN is a feature of the evolution of aggressive
colorectal adenocarcinoma right from the outset, being evident in the
smallest adenomas, and multiple reports have directly linked
oncogenic APC mutations in colorectal cancer with a predisposition
to CIN (Dikovskaya et al., 2007; Fodde et al., 2001; Kaplan et al.,
2001). Importantly, embryonic stem cells derived from Apc1638T/1638T
mice develop hallmarks of CIN (Fodde et al., 2001), and
overexpression of truncated APC lacking the C-terminal domains in
chromosomally stable colorectal cancer cells leads to mitotic defects,
including errors in kinetochore attachment and alignment of
chromosomes (Green and Kaplan, 2003; Tighe et al., 2004).
Fig. 3. Organoids recapitulate the consequences of Apc inactivation in
the intestinal epithelia. (A) Fluorescence confocal microscopy of small
intestinal epithelial organoids (top panels) and ApcMin/− tumouroids (bottom
panels). All cells were labelled with DAPI (blue) and fluorescent phalloidin
(green; left panel), or antibodies against β4-integrin (green; middle left panel),
β-catenin (red; middle right panel) and ZO-1 (red; right panel). ‘A’ marks the
apical domain of cells in the monolayers and ‘B’ marks the basal domain.
(B) Organoids (top panels) and ApcMin/− tumouroids (bottom panels) were
labelled by immunofluorescence using antibodies against β-tubulin and
acetylated-α-tubulin, as marked. All cells were labelled with DAPI (blue). ‘A’
marks the apical domain of cells in the monolayers and ‘B’ marks the basal
domain. (C) Immunofluorescence of small intestinal epithelial organoids (left
panels) and ApcMin/− tumouroids (right panels). The top panels show labelling
with fUEA (red) and an antibody against β4-integrin (green). Middle panels
show labelling with antibodies against pericentrin (red) and an antibody against
β4-integrin (green). Bottom panels show labelling with antibodies against
ZFPL1 (red) and an antibody against ZO-1 (green). All cells were labelled with
DAPI (blue). ‘A’ marks the apical domain of cells in the monolayers and ‘B’
marks the basal domain. (D) The cellular positioning of the centrosome and the
Golgi was scored as apical or apical and clustered in organoids (orgs) or
tumouroids (tums), according to the schematics in the right panels for >200
cells from three independent experiments. Data are mean±s.d. Statistical
differences in centrosome and Golgi localisation in tumouroids relative to
organoids were determined by an unpaired one-tailed Student’s t-test
(*P<0.01, **P<0.001). Scale bars, 50 μm.
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Fig. 4. See next page for legend.
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However, the molecular relationship between Apc loss, microtubule
deregulation and chromosome instability in the intestinal epithelia has
yet to be established. The experimentally tractable organoid/
tumouroid model system we have developed will be invaluable in
determining the role of Apc in the loss ofmicrotubule integrity and the
impact of CIN in intestinal tumorigenesis.
Our results distinguish individual malignant properties of
intracellular disorganisation, compromised tissue morphology and
proliferation as direct but independent consequences of Apc
inactivation; we posit that the combination of these emergent
properties creates a ‘perfect storm’ for malignant transformation of
the rapidly dividing intestinal epithelia, explaining why this tissue is
particularly vulnerable to oncogenic Apc mutations.
MATERIALS AND METHODS
Reagents, antibodies and molecular probes
Doxycycline and nocodazole were sourced from Sigma-Aldrich and used at
concentrations of 2 μg/ml and 100 nM, respectively. Wnt3A-conditioned
mediumwas harvested fromWnt3A-expressing L-cells (ATCC, CRL-2647)
according to a previously established protocol (Willert et al., 2003). The
medium was stored for up to 2 months at 4°C without any detectable loss of
Wnt3A activity. Antibodies and molecular probes used for fluorescence
microscopy are listed in Table 2.
Tissue preparation and fluorescent labelling
All procedures using mice were performed under the UK Home Office
guidelines. Intestines obtained from wild-type CL57BL/6, Apc1638T/1638T,
ApcMin/+ CL57BL/6, Apcfl/fl LSL tdTom (a gift from the Winton laboratory,
CRUKCambridge Institute, Cambridge, UK) andMyc-335−/− (a gift from the
Taipale laboratory, Department of Biochemistry, University of Cambridge,
UK) mice were either fixed in 4% formaldehyde and embedded in paraffin or
fixed-frozen in 10% formalin and embedded in optimal cutting temperature
liquid, followed by snap freezing (fresh-frozen tissue).
Small intestinal epithelial sections (4% formaldehyde fixed or fresh
frozen) for molecular probe and antibody labelling were cut at 4.5 μm onto
slides. The exception was slides labelled with β-tubulin or acetylated
tubulin, in which case 20 μm formaldehyde-fixed sections were cut onto
poly-L-lysine-coated slides.
For formaldehyde-fixed samples, epitope retrieval was performed in
sodium citrate buffer (sodium citrate 10 mM and 0.05% Tween 20, pH 6.0).
Primary antibody incubations were carried out at 4°C overnight and
secondary antibody incubation for 2 h at room temperature, both in PBS
containing normal goat serum (5%) and 0.1% Tween 20. Samples were
mounted in DAPI-containing Fluoromount-G (Thermo-Fisher).
Organoid preparation and fluorescent labelling
Murine small intestinal epithelial organoids were derived from the ileum of
mouse small intestine according to Sato and Clevers (2013). Tumouroids
were derived from tumours within the ileum of 110 day-old ApcMin/+ mice
(Haigis et al., 2004). All organoids and tumouroids were cultured according
to Urbischek et al. (2019).
Organoids were seeded in Matrigel onto eight-well chamber slides
(Thermo Fisher Scientific) 48 h before fluorescent labelling, which involved
fixation in 92% methanol containing 8% formaldehyde, followed by
labelling according to a published protocol (Goldspink et al., 2017).
Organoids in primary antibody were incubated at 4°C overnight. The next
day the slides were incubated at room temperature for 1 h (allowing the
Matrigel to harden), washed and then incubated for 1 h at room temperature
in the secondary antibody. Labelled organoid samples were then mounted in
DAPI-containing Fluoromount-G.
Organoid and tissue imaging and data analysis
Fluorescent imaging of tissue was carried out using a Nikon C2 plus
confocal microscope using a 40× objective lens. Images were processed
using ImageJ software. Fluorescent labelling of each antibody was repeated
a minimum of three times.
Imaging of organoids was carried out using a Nikon C2 plus confocal
microscope using the 20× and 40× objectives, and an automated spinning
disc confocal microscope (Yokogawa Cell Voyager CV8000) using a 40×
objective. The z-stacks were taken at 1 μm steps. Images were processed and
published using ImageJ software. All figures presented are representative
images from a single plane within the z-stack of the imaged specimen. For
the quantification of organelle positioning within organoids, ∼200 cells
were manually counted per experiment. Statistical variation of phenotypes
among treatment groups and genotypes was calculated by one and two-
tailed Student’s t-tests using GraphPad Prism software. Except where noted,
all Student's t-tests were unpaired.
Plasmids and organoid expression
The piggybac transposon and Tet-on expression system were kind gifts from
Bon-Kyoung Koo (Institute of Molecular Biotechnology, Vienna, Austria).
The previously validated shRNA targeting mouse Apc (Dow et al., 2015)
was inserted into the tet-responsive shRNA expression vector pB-TRE-
IRES-mCherry. The three plasmid system also consists of pB-CAG-rtTA,
the vector for constitutive rtTA expression, and pPiggybac, the expression
vector for constitutive expression of the piggybac transposase (Fujii et al.,
2015).
The shApc organoid line was generated by transfection of the pB-TRE-
shApc-IRES-mCherry, pPiggybac and pB-CAG-rtTA plasmids (Fig. S2A)
using a NEPA21 electroporator according to a previously published protocol
(Fujii et al., 2015). Organoids were selected for integration of constructs in
organoid medium containing Wnt3A-conditioned medium (Urbischek
et al., 2019) supplemented with 150 μg/ml Hygromycin B (Thermo
Fisher Scientific) for 7 days, after which the medium was switched to
organoid medium (Urbischek et al., 2019).
Fig. 4. Switchable in vitro model of tumorigenesis recapitulates the
consequences of Apc inactivation in the intestinal epithelia. (A) An
organoid line bearing pB-shApc, the Tet-on inducible transgene system for the
induction of shApc expression (Fig. S2), untreated (top panels), treated with
doxycycline for 10 days (middle panels), or the former followed by doxycycline
withdrawal for an additional 6 days (lower panels). The left panels show
fluorescence confocal microscopy of organoids labelled with fUEA (red). The
middle panels show organoids labelled with antibodies to pericentrin
(centrosome, red). The right panels show organoids labelled with antibodies
against ZFPL1 (Golgi, white). All specimens were co-labelled with an antibody
against β4-integrin (green) and DAPI (blue). ‘A’ marks the apical domain of
cells in the monolayers and ‘B’ marks the basal domain. (B) Fluorescence
confocal microscopy of organoids (left panels) and tumouroids (right panels)
treated with Wnt3A-conditioned medium for 72 h and labelled with antibodies
as marked. The top panels show specimens co-labelled with antibodies
against pericentrin (centrosome, red) and β4-integrin (green). The bottom
panels show specimens co-labelled with antibodies against ZFPL1 (Golgi, red)
and ZO-1 (green). All specimens were co-labelled with DAPI (blue). The right
panels show graphs quantifying apical localisation of centrosome and apical
clustering of Golgi for the Wnt-oids and tumouroids treated with Wnt3A. More
than 200 cells from three independent fluorescent sections were analysed
according to the schematic in Fig. 3D. (C) Top: schematic depicting the
nocodazole treatment regime for organoid, Wnt-oid and tumouroid cultures.
The panels below show fluorescence confocal microscopy of cultures treated
as follows: control (I); treated with nocodazole (II); or nocodazole treatment
followed by drug withdrawal for 72 h (III). All panels show labelling with
fluorescent phalloidin (green) and DAPI (blue), and probed with an antibody
against ZFPL1 (Golgi, red). ‘A’ marks the apical domain of cells in the
monolayers and ‘B’ marks the basal domain. (D) Top: quantification of apical
Golgi clustering (according to the schematic in Fig. 3D). Bottom: percentage of
organoid morphology among the nocodazole treatment groups quantified as
the percentage of organoids that maintained two or more crypts under the
treatment conditions. Data are mean±s.d. and derived from analysis of 50
organoids from two independent experiments. Statistical differences among
organoid, Wnt-oid and tumouroid phenotypes (B), and for Golgi localisation for
treated samples (D, II and III) relative to control (D, I) were calculated using an
unpaired two-tailed Student’s t-test (*P<0.001). There were no significant
differences in organoid morphology among the treatment groups in D. Scale
bars: 50 μm.
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Validation of shApc organoid line
For western blotting, organoids were recovered from Matrigel using several
rinses of ice-cold PBS, and the pellet was lysed with 50 μl 1× RIPA buffer
(Millipore) containing protease (Sigma-Aldrich) and phosphatase inhibitors
(Roche). Samples were loaded onto NuPAGE 3-8% Tris-acetate gradient
gels (Thermo Fisher Scientific) before transfer onto a PVDF membrane.
Antibodies used for probing membranes in PBS containing 0.2% Tween 20
and 5% non-fat milk are in Table 2.
Expression levels of Apc and mCherry were determined by qRT-PCR.
RNAwas isolated from organoids and tumouroids using the ReliaPrep RNA
Cell Miniprep System kit (Promega) and cDNA was prepared using the
High Capacity cDNA Reverse Transcription kit (Thermo Fisher Scientific),
all according to the manufacturers’ instructions. qRT-PCR was carried out
using Fast SYBR Green Master Mix using a QuantStudio 5 real-time PCR
system (both Applied Biosystems). B2m was used as a housekeeping gene
and relative fold changes in Apc and mCherry expression were derived from
ΔΔCT. The following primers were used: Apc forward, 5′-AGCCATGC-
CAACAAAGTCATCACG-3′, Apc reverse, 5′-TTCCTTGCCACAGGTG-
GAGGTAAT-3′; mCherry forward, 5′-CACGAGTTCGAGATCGAGGG-3′,
mCherry reverse, 5′-CAAGTAGTCGGGGATGTCGG-3′; and B2m forward
Fig. 5. The Wnt pathway target gene c-Myc does not specify tissue morphology and intracellular organisation upon Wnt pathway activation.
(A) Representative bright-field images of wild-type and Myc-335−/− organoids grown in increasing concentrations of Wnt3A-conditioned medium for 7 days.
(B) Quantification of Wnt-oid formation under conditions described above. Data displayed is derived from a minimum of 200 individual organoids from two
independent experiments for each concentration of Wnt3A-conditioned medium. nd, no Wnt-oids detected. (C) Fluorescence confocal microscopy of wild-type
and Myc-335−/− organoids grown in the absence or presence of the maximal dose of Wnt3A-conditioned medium for 7 days. All sections were labelled with
DAPI (blue), fluorescent phalloidin (green) and an antibody against ZFPL1 (Golgi, red). (D) Growth rate measured as averageWnt-oid diameter (µM) of wild-type
and Myc-335−/− organoids after 7 days growth in 100% Wnt3A-conditioned medium. Data for the box plots was from more than 50 organoids from two
independent experiments for each organoid type. Boxes show the interquartile range, with the median indicated. Whiskers show the range. (E) Model for Apc
regulation of proliferation, tissuemorphology and intracellular organisation in the small intestinal epithelia. Red arrows represent Apc effector pathways stratified in
the current study. See text for details. Data are mean±s.d. No statistically significant differences were observed in the frequency of Wnt-oid morphology (B) or in
growth rate between organoid genotypes (D), as evaluated using an unpaired two-tailed Student’s t-test. Scale bars: 1000 μm (A); 50 μm (C).
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5′-ACCCCCACTGAGACTGATAC-3′, B2m reverse, 5-ATCTTCAGAG-
CATCATGATG-3.
Genotyping of Myc-335−/− mice
Primer pairs used for the genotyping of mice were U3An2 and UcSe2 for
wild-type allele, and U3An2 and U5Se2 for the Myc-335 null allele. The
sequence of these primers are as follows:
U3An2, 5′-TATCTGCGGGTAGTACACCTGT-3′; U5Se2, 5′-TAGTG-
ATTGGGTAATAAAGAATGAGGTC-3′; and UcSe2, 5′-GCTGACAG-
AGATTGCTGACATAA-3′ (Sur et al., 2012). The expected amplicon
sequences of the two alleles are shown in Table S1.
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Figure S2. The pB-shApc switchable model of in vitro tumorigenesis/tumour regression 
recapitulates the phenotypic consequences of oncogenic Apc mutations. A. Transgenes used 
for the construction of the control pB-mCherry or pB-shApc organoid lines. The shApc 
expression transgenic system includes pB-CAG-rtTA for constitutive rtTA expression and the 
plasmid for expression of the piggybac transposase for stable integration into organoids. In-
built tet-on system enables inducible expression of shApc linked to mCherry by treatment of 
pB-shApc organoids with doxycycline. B. Time-course of doxycycline treatment (dox) of pB-
shApc organoids; after ten days organoids convert to spheroids accompanied by mCherry 
expression. Subsequent withdrawal of doxycycline and growth for an additional 6 days (post-
dox) restores the budding organoid morphology. Scale bar, 200 μm. C. Quantification of the 
conversion of spheroid morphology to budding organoids morphology upon withdrawal of 
doxycycline over the course of 6 days. Grey boxes represent the remaining spheroids as a 
percentage of the total; white boxes are the number of organoids that have intra-converted 
from spheroids. Data is derived from greater that 100 organoids from two independent 
experiments scored at each timepoint. Statistical differences between organoid and spheroid 
morphologies were evaluated using the two-tailed student’s t-test, error bars± SD. D. QRT-PCR 
quantification of relative Apc (top graph) and mCherry expression (bottom graph) in pB-
mCherry control organoids (engineered for inducible expression of mCherry) and pB-shApc 
organoids (engineered for inducible expression of mCherry and shApc) after two days 
doxycycline treatment (dox) and at 6-days post-withdrawal (post-dox). Values for Apc and 
mCherry expression levels are presented with error bars, ± SD. Statistical differences in 
expression levels after 6-days post-withdrawal relative to doxycycline treated organoids at the 
p<0.001 level of significance is (calculated using a paired Student's t-test) represented by ‘*’. E. 
Protein lysates from control (pB-Cherry) organoids or pB-shApc organoids with various 
treatments (no treatment, 2 days doxycycline treatment, 6 days post-doxycycline withdrawal; 
post-dox), shown above, were subject to western blot and probed with antibodies to c-Myc and 
vinculin as loading control. Quantified relative expression of c-Myc in the lysates were derived 
from densitometry of the corresponding western blot signals.

































Figure S3. Genotyping of intestinal epithelia from 
Myc-335-/- mouse used in this study (Sur et al., 2012). 
PCR genotyping of Myc-335-/-intestinal epithelia using 
primers targeting the wild-type (WT; target amplicon 
length is 227 bp) or Myc- 335 mutant allele (mut; 
amplicon length is 311 bp)(Sur et al., 2012).

























Table S1. Expected amplicon sequences of the two Myc-335 alleles. 
Myc-335wt (227 bp) Myc-335null (311 bp) 
GCTGACAGAGATTGCTGACATAAATAAAGTGTG
CTCCAAGTGTTTGCTCAGCTCTGGGCTCAGCCAG
GACAGATGCAGCTTCTTGAATGTCATTCCCAAGA
TATCCTGGAGGTATTTAGCTTCCCTCCCTCTACTC
TGGAAAAGATACCATGGGCAACATCAGTACAGA
CGATGCTGATATATCCTGACAGAGTATCCCCACT
GGACAGGTGTACTACCCGCAGATA 
TAGTGATTGGGTAATAAAGAATGAGGTCAAGG
AACGGATAATGTAGGGAACAGTGCCTGAGTGT
AAGGCAAAAGGCAGAGAATTCCTAGGTTCTAG
AACCGGTGACGTCAAGCTCGAATAACTTCGTA
TAATGTATGCTATACGAAGTTATTAGGTCCCTC
GAAGAGGTTCACTAGTACTGGCCAATCGGCGC
GCCTAGGTAGCTTCCCTCCCTCTACTCTGGAAA
AGATACCATGGGCAACATCAGTACAGACGATG
CTGATATATCCTGACAGAGTATCCCCACTGGAC
AGGTGTACTACCCGCAGATA 
